The Ludwig Center at Harvard investigates and seeks to overcome the resistance of cancer cells to current and emerging therapies.
While significant advances have been made in the treatment of cancer, both primary and acquired resistance remain major challenges to reducing the burden of cancer. Basic scientists and physician-investigators from across the Harvard Medical School work together at our Center to study how changes in the genomes of cancer cells and other unique factors within the tumor and its local environment converge to generate such resistance. We integrate orthogonal perspectives, tools and investigative strategies across disciplines to address these questions and devise new approaches to maximize the impact of anticancer therapies.
Click here to download the PowerPoint slides presented at the informational sessions across Harvard and learn more about the Collaborative Cancer Research Challenge at Harvard.
The Ludwig Center is housed within the Dana-Farber Cancer Institute with operational units extending throughout leading laboratories and hospitals affiliated with the Harvard Medical School in Boston, Massachusetts, USA, including Brigham and Women’s Hospital, Children’s Hospital of Boston and Massachusetts General Hospital, as well as the Broad Institute in Cambridge, Massachusetts.
Ludwig Center at Harvard
450 Brookline Avenue
Boston, Massachusetts, U.S. 02215
T 617 632 3985
F 617 632 3408